arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Olema Pharmaceuticals, Inc.

OLMA Health Care Biotechnology: Pharmaceutical Preparations
$6.41
▼ -9.1% Today
as of Oct 23, 16:51 ET
Last 30 days -37.71% Sep 14 → Oct 23
$6.10 $7.22 $8.35 $9.48 $10.60 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$6.93
High
$6.94
Low
$6.24
Volume
$2M
Avg Vol
$2M
Mkt Cap
$724M
P/E (TTM)
—
Beta
—
52w High
$36.26
52w Low
$6.24
Div Yield
—
Shares Out
$87M

Recent Press Releases & News last 60 days · 4 items

Oct 2 · 20:30 PR GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 14 · 12:10 InvestorsHub
Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results
Sep 2 · 20:30 PR GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
▸ Show all 4 press releases & news Free account →

OLMA earnings at a glance

The options market is pricing a move of about ±14.7% after the report, a range of roughly $5.46 to $7.36 from today's $6.41. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±3.8% on average; after the most recent report on May 12, 2026 it moved -6.0%. That means options currently expect more movement than OLMA has typically delivered. OLMA beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 125%. The share price of $6.41 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$6.24
$36
1% of range
Avg surprise (last 4)
-0.9%
Avg reaction (last 2)
-3.8%
0% positive
Latest IV / EM
125%
EM ±14.7% · $8 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.70$-0.61$-0.53$-0.44$-0.36 Actual $-0.70Actual $-0.49Actual $-0.48Actual $-0.56Actual $-0.54Actual $-0.60Actual $-0.36Est $-0.49Actual $-0.51Est $-0.43Actual $-0.49Est $-0.44Actual $-0.52Est $-0.52Actual $-0.61 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-63M$-55M$-48M$-40M$-32M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.61 — — — — financials
Tue May 12, 2026Mar/2026 $-0.52 $-0.52 0.0% -44.4% -6.0% earnings
Mon Nov 10, 2025Sep/2025 $-0.49 $-0.44 -11.4% — — earnings
Mon Aug 11, 2025Jun/2025 $-0.51 $-0.43 -18.6% — — earnings
Tue May 13, 2025Mar/2025 $-0.36 $-0.49 +26.5% — -1.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.60 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.54 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.56 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.48 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.49 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.70 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-67M$-58M—$-46M$-48M$-35M—$-38M
Net income$-63M$-53M—$-42M$-44M$-30M—$-35M
EPS (diluted)$-0.61$-0.52—$-0.49$-0.51$-0.36—$-0.60

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$49M$53M$48M$35M$52M$51M$139M$36M
Inventory————————
Total current assets$470M$513M$515M$334M$368M$397M$438M$218M
Total assets$487M$531M$533M$352M$382M$410M$451M$230M
Long-term debt————————
Total liabilities$56M$50M$55M$45M$37M$26M$42M$31M
Total equity$431M$480M$479M$307M$345M$383M$409M$199M

Implied volatility — last 90 days

42%208%374%540%706% Jun 07 — IV 350% · EM ±48.5%Jun 08 — IV 388% · EM ±51.2%Jun 09 — IV 304% · EM ±38.1%Jun 10 — IV 147% · EM ±17.3%Jun 11 — IV 109% · EM ±12.1%Jun 12 — IV 94% · EM ±9.6%Jun 15 — IV 707% · EM ±51.1%Jun 19 — IV 73% · EM ±16.0%Jun 23 — IV 102% · EM ±20.9%Jun 24 — IV 238% · EM ±47.6%Jun 25 — IV 151% · EM ±29.5%Jun 26 — IV 229% · EM ±43.9%Jun 29 — IV 228% · EM ±40.4%Jul 02 — IV 240% · EM ±38.8%Jul 03 — IV 248% · EM ±38.8%Jul 06 — IV 42% · EM ±5.9%Jul 09 — IV 55% · EM ±6.5%Jul 10 — IV 58% · EM ±6.4%Jul 13 — IV 520% · EM ±43.5%Jul 20 — IV 90% · EM ±21.1%Jul 21 — IV 186% · EM ±43.1%Jul 22 — IV 129% · EM ±29.6%Jul 23 — IV 187% · EM ±42.2%Jul 27 — IV 79% · EM ±16.5%Jul 28 — IV 138% · EM ±28.2%Aug 03 — IV 278% · EM ±49.2%Aug 04 — IV 74% · EM ±12.8%Aug 05 — IV 77% · EM ±12.9%Aug 10 — IV 321% · EM ±44.4%Aug 11 — IV 65% · EM ±8.6%Aug 12 — IV 69% · EM ±8.6%Aug 18 — IV 701% · EM ±50.7%Aug 20 — IV 143% · EM ±6.0%Aug 24 — IV 85% · EM ±17.7%Aug 25 — IV 92% · EM ±18.8%Aug 26 — IV 89% · EM ±17.7%Aug 27 — IV 90% · EM ±17.6%Aug 28 — IV 146% · EM ±28.0%Aug 31 — IV 216% · EM ±38.4%Sep 01 — IV 77% · EM ±13.3%Sep 02 — IV 97% · EM ±16.2%Sep 04 — IV 84% · EM ±13.1%Sep 07 — IV 96% · EM ±13.3%Sep 08 — IV 91% · EM ±12.0%Sep 09 — IV 81% · EM ±10.1%Sep 11 — IV 628% · EM ±69.4%Sep 21 — IV 168% · EM ±35.1%Sep 22 — IV 93% · EM ±18.9%Sep 23 — IV 275% · EM ±55.1%Sep 24 — IV 202% · EM ±39.5%Sep 25 — IV 110% · EM ±21.0%Sep 30 — IV 114% · EM ±19.1%Oct 07 — IV 90% · EM ±11.3%Oct 08 — IV 125% · EM ±14.7%

Sector peers

DSGN
Design Therapeutics, Inc.
$732M $10.24-4.6%
WVE
Wave Life Sciences, Inc.
$765M $3.18-5.6%
MDXG
MiMedx Group, Inc
$672M $3.91+4.5%
LXRX
Lexicon Pharmaceuticals, Inc.
$783M $1.42-9.0%
NVCT
Nuvectis Pharma, Inc.
$662M $20.05-3.1%
ESPR
Esperion Therapeutics, Inc.
$819M $3.18

OLMA earnings FAQ

What is OLMA's expected move for earnings?

Options currently price a move of about ±14.7%, or $0.95 per share either way from $6.41.

How does OLMA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.8%, up 0 times and down 2 times.

What is OLMA's implied volatility?

OLMA's at-the-money implied volatility is about 125% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in